ERBB2 and neoplasm: In this report, we experienced the patient who presented with synchronous locally advanced bilateral breast cancers with different tumor biology: the left breast cancer was hormone receptor (HR)-negative and HER2-positive, meanwhile the right breast cancer was HR-positive and HER2-negative status.